z-logo
open-access-imgOpen Access
Late and booster anti‐SARS‐CoV ‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
Author(s) -
Bakasis AthanasiosDimitrios,
Goules Andreas V.,
Vlachoyiannopoulos Panayiotis G.,
Bitzogli Kleopatra,
Tzioufas Athanasios G.
Publication year - 2022
Publication title -
acr open rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2578-5745
DOI - 10.1002/acr2.11446
Subject(s) - medicine , rituximab , antibody , seroconversion , vaccination , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom